Literature DB >> 7282783

The mucolipidoses: identification by abnormal electrophoretic patterns of lysosomal hydrolases.

N K Honey, A L Miller, T B Shows.   

Abstract

The human mucolipidoses (ML) are characterized by abnormal activities and abnormal electrophoretic patterns of fibroblast lysosomal hydrolases. These altered mobility patterns can be used to confirm the clinical diagnosis of the four mucolipidoses. The mobility patterns of one nonlysosomal and seven lysosomal enzymes were tested in fibroblasts from two ML I (sialidosis type 2, infantile), fifteen ML II (I-cell disease), eight ML III (pseudohurler polydystrophy), and one ML IV patients. A single sialidosis type 2, juvenile, line was also examined. Characteristic mobility patterns were found which identify each of the four mucolipidoses. Both the ML I and sialidosis type 2 juvenile lines displayed anodal mobility patterns, but distinct differences between the two disorders were observed. Lysosomal hydrolases from ML II lines demonstrated reduced activities or had altered mobilities. Differing electrophoretic patterns demonstrated the presence of at least two groups within the clinical phenotype diagnosed as ML II, indicating heterogeneity. The ML III lines showed normal electrophoretic patterns for most lysosomal hydrolases. The ML IV line expressed normal mobilities for every enzyme studied, with a single exception. The electrophoretic patterns of only beta-hexosaminidase, acid phosphatase-2, alpha-galactosidase, and esterase A4 were sufficient to identify and distinguish the different mucolipidosis types. Electrophoretic variation was also seen in liver but not kidney extracts from three ML II patients. beta-Hexosaminidase and alpha-mannosidase B secreted into the medium by ML II and ML III fibroblasts had mobility patterns different from normal and from their intracellular patterns. These data suggest that the mucolipidoses are genetically distinct with heterogeneity within them.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7282783     DOI: 10.1002/ajmg.1320090310

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Genetically defined lysosomal acetylesterase EC 3.1.1.6 in the cauda epididymidis of mouse, rat, and man.

Authors:  J Trefzger; A Ronai; B Wassmer; O von Deimling
Journal:  Histochemistry       Date:  1992-12

2.  Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy.

Authors:  Y Ben-Yoseph; M Potier; D A Mitchell; B A Pack; S B Melançon; H L Nadler
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

3.  Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II.

Authors:  Sandra Markmann; Svenja Krambeck; Christopher J Hughes; Mina Mirzaian; Johannes M F G Aerts; Paul Saftig; Michaela Schweizer; Johannes P C Vissers; Thomas Braulke; Markus Damme
Journal:  Mol Cell Proteomics       Date:  2017-01-06       Impact factor: 5.911

4.  A variant of mucolipidosis. II. Clinical, biochemical and pathological investigations.

Authors:  L Poenaru; L Castelnau; F Tome; J Boue; P Maroteaux
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

5.  Homozygosity for the variant alpha-L-fucosidase trait and mucolipidosis III.

Authors:  R Gatti; C Lombardo; P P Cardo
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Mucolipidosis III is genetically heterogeneous.

Authors:  N K Honey; O T Mueller; L E Little; A L Miller; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations.

Authors:  Y Ben-Yoseph; D A Mitchell; R M Yager; J T Wei; T H Chen; L Y Shih
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

8.  Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency.

Authors:  O T Mueller; T B Shows
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.

Authors:  O T Mueller; N K Honey; L E Little; A L Miller; T B Shows
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.